Medical device maker Medtronic plc (NYSE: MDT) on Tuesday reported an increase in revenues and adjusted profit for the third quarter of 2025.
![](data:image/svg+xml;charset=utf-8,<svg height="2089px" width="1280px" xmlns="http://www.w3.org/2000/svg" version="1.1"/>)
Third-quarter earnings, excluding special items, rose 7% year-over-year to $1.39 per share. On an unadjusted basis, net profit was $1.30 billion or $1.01 per share in Q3, compared to $1.32 billion or $0.99 per share in the same period of 2024.
Revenues of Cardiovascular and Neuroscience, the main operating segments, increased by 4%. Total revenues grew 2% year-over-year to $8.3 billion during the three months.
